The mammary myoepithelial cell

International Journal of Developmental Biology

Volumn 55, Issue 7-9, 2011, Pages 763-771

  Moumen, Mejdi ^a   Chiche, Aurélie ^a   Cagnet, Stéphanie ^a   Petit, Valérie ^a   Raymond, Karine ^a   Faraldo, Marisa M ^a   Deugnier, Marie Ange ^a   Glukhova, Marina A ^a  

^a INSTITUT CURIE   (France)

Author keywords

Differentiation; Extracellular matrix; Intercellular signaling; Stem cells; Tumorigenesis

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; DEVELOPMENTAL STAGE; EXTRACELLULAR MATRIX; HUMAN; MAMMARY MYOEPITHELIAL CELL; MOLECULAR MECHANICS; MUSCLE FIBER CONTRACTION; MYOEPITHELIOMA; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REGULATORY MECHANISM; STEM CELL; TISSUE REGENERATION;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL COMMUNICATION; CELL DIFFERENTIATION; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MYOEPITHELIOMA; PARACRINE COMMUNICATION; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 82555181312     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.113385mm     Document Type: Article

References (53)

1. ANBAZHAGAN R, OSIN PP, BARTKOVA J, NATHAN B, LANE EB and GUSTERSON BA (1998). The development of epithelial phenotypes in the human fetal and infant breast. J Pathol 184: 197-206.
2. ANDRES AC and ZIEMIECKI A (2003). Eph and ephrin signaling in mammary gland morphogenesis and cancer. J Mammary Gland Biol Neoplasia 8: 475-485.
3. ASSELIN-LABAT ML, VAILLANT F, SHERIDAN JM, PAL B, WU D, SIMPSON ER, YASUDA H, SMYTH GK, MARTIN TJ, LINDEMAN GJ and VISVADER JE (2010). Control of mammary stem cell function by steroid hormone signalling. Nature 465: 798-802.
4. BAI L and ROHRSCHNEIDER LR (2010). s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev 24: 1882-1892.
5. BARSKY SH and KARLIN NJ (2006). Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell. Nat Clin Pract Oncol 3: 138-151.
6. BOURAS T, PAL B, VAILLANT F, HARBURG G, ASSELIN-LABAT ML, OAKES SR, LINDEMAN GJ and VISVADER JE (2008). Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 3: 429-441.
7. BRISKEN C and O'MALLEY B (2010). Hormone action in the mammary gland. Cold Spring Harb Perspect Biol 2: a003178.
8. BUZA N, ZEKRY N, CHARPIN C and TAVASSOLI FA (2010). Myoepithelial carcinoma of the breast: a clinicopathological and immunohistochemical study of 15 diagnostically challenging cases. Virchows Arch 457: 337-345.
9. CHOI YS, CHAKRABARTI R, ESCAMILLA-HERNANDEZ R and SINHA S (2009). Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. Dev Biol 329: 227-241.
10. DEUGNIER MA, FARALDO MM, TEULIERE J, THIERY JP, MEDINA D and GLUKHOVA MA (2006). Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev Biol 293: 414-425.
11. DEUGNIER MA, MOISEYEVA EP, THIERY JP and GLUKHOVA M (1995). Myoepithelial cell differentiation in the developing mammary gland: progressive acquisition of smooth muscle phenotype. Dev Dyn 204: 107-117.
12. DONTU G, JACKSON KW, MCNICHOLAS E, KAWAMURA MJ, ABDALLAH WM and WICHA MS (2004). Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6: R605-615.
13. FARALDO MM, TEULIERE J, DEUGNIER MA, BIRCHMEIER W, HUELSKEN J, THIERY JP, CANO A and GLUKHOVA MA (2007). beta-Catenin regulates P-cadherin expression in mammary basal epithelial cells. FEBS Lett 581: 831-836.
14. FARALDO MM, TEULIERE J, DEUGNIER MA, TADDEI-DE LA HOSSERAYE I, THIERY JP and GLUKHOVA MA (2005). Myoepithelial cells in the control of mammary development and tumorigenesis: data from genetically modified mice. J Mammary Gland Biol Neoplasia 10: 211-219.
15. FOULKES WD, SMITH IE and REIS-FILHO JS (2011). Triple-negative breast cancer. N Engl J Med 363: 1938-1948.
16. FRIEDRICHS N, STEINER S, BUETTNER R and KNOEPFLE G (2007). Immunohistochemical expression patterns of AP2alpha and AP2gamma in the developing fetal human breast. Histopathology 51: 814-823.
17. GUSTERSON B (2009). Do 'basal-like' breast cancers really exist? Nat Rev Cancer 9: 128-134.
18. HAAKSMA CJ, SCHWARTZ RJ and TOMASEK JJ (2011). Myoepithelial cell contraction and milk ejection are impaired in mammary glands of mice lacking smooth musclealpha-actin. Biol Reprod DOI:10.1095/biolreprod.110.090639.
19. HARTSHORNE DJ, ITO M and IKEBE M (1989). Myosin and contractile activity in smooth muscle. Adv Exp Med Biol 255: 269-277.
20. HYNES RO (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
21. INCASSATI A, CHANDRAMOULI A, EELKEMA R and COWIN P (2010). Key signaling nodes in mammary gland development and cancer: beta-catenin. Breast Cancer Res 12: 213.
22. JOLICOEUR F (2005). Intrauterine breast development and the mammary myoepithelial lineage. J Mammary Gland Biol Neoplasia 10: 199-210.
23. JOSHI PA, JACKSON HW, BERISTAIN AG, DI GRAPPA MA, MOTE PA, CLARKE CL, STINGL J, WATERHOUSE PD and KHOKHA R (2010). Progesterone induces adult mammary stem cell expansion. Nature 465: 803-807.
24. KENDRICK H, REGAN JL, MAGNAY FA, GRIGORIADIS A, MITSOPOULOS C, ZVELEBIL M and SMALLEY MJ (2008). Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 9: 591.
25. KHRAMTSOV AI, KHRAMTSOVA GF, TRETIAKOVA M, HUO D, OLOPADE OI and GOSS KH (2010). Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol 176: 2911-2920.
26. LAZARD D, SASTRE X, FRID MG, GLUKHOVA MA, THIERY JP and KOTELIANSKY VE (1993). Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 90: 999-1003.
27. LIM E, VAILLANT F, WU D, FORREST NC, PAL B, HART AH, ASSELIN-LABAT ML, GYORKI DE, WARD T, PARTANEN A, FELEPPA F, HUSCHTSCHA LI, THORNE HJ, FOX SB, YAN M, FRENCH JD, BROWN MA, SMYTH GK, VISVADER JE and LINDEMAN GJ (2009). Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-913.
28. LIM E, WU D, PAL B, BOURAS T, ASSELIN-LABAT ML, VAILLANT F, YAGITA H, LINDEMAN GJ, SMYTH GK and VISVADER JE (2010). Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res 12: R21.
29. MACIAS H, MORAN A, SAMARA Y, MORENO M, COMPTON JE, HARBURG G, STRICKLAND P and HINCK L (2011). SLIT/ROBO1 signaling suppresses mammary branching morphogenesis by limiting basal cell number. Dev Cell 20: 827-840.
30. MANI SA, GUO W, LIAO MJ, EATON EN, AYYANAN A, ZHOU AY, BROOKS M, REINHARD F, ZHANG CC, SHIPITSIN M, CAMPBELL LL, POLYAK K, BRISKEN C, YANG J and WEINBERG RA (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
31. MOLYNEUX G, GEYER FC, MAGNAY FA, MCCARTHY A, KENDRICK H, NATRAJAN R, MACKAY A, GRIGORIADIS A, TUTT A, ASHWORTH A, REIS-FILHO JS and SMALLEY MJ (2010). BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7: 403-417.
32. MORITA T, MAYANAGI T and SOBUE K (2007). Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J Cell Biol 179: 1027-1042.
33. MORROW D, GUHA S, SWEENEY C, BIRNEY Y, WALSHE T, O'BRIEN C, WALLS D, REDMOND EM and CAHILL PA (2008). Notch and vascular smooth muscle cell phenotype. Circ Res 103: 1370-1382.
34. MUSCHLER J and STREULI CH (2010). Cell-matrix interactions in mammary gland development and breast cancer. Cold Spring Harb Perspect Biol 2: a003202.
35. NACCARATO AG, VIACAVA P, VIGNATI S, FANELLI G, BONADIO AG, MONTRUCCOLI G and BEVILACQUA G (2000). Bio-morphological events in the development of the human female mammary gland from fetal age to puberty. Virchows Arch 436: 431-438.
36. PANDEY PR, SAIDOU J and WATABE K (2011). Role of myoepithelial cells in breast tumor progression. Front Biosci 15: 226-236.
37. PASIC L, EISINGER-MATHASON TSK, VELAYUDHAN BT, MOSKALUK CA, BRENIN DR, MACARA IG, LANNIGAN DA (2011). Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue. Genes Dev 25: 1641-1653.
38. PIPES GC, CREEMERS EE and OLSON EN (2006). The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 20: 1545-1556.
39. PROIA TA, KELLER PJ, GUPTA PB, KLEBBA I, JONES AD, SEDIC M, GILMORE H, TUNG N, NABER SP, SCHNITT S, LANDER ES and KUPERWASSER C (2010). Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell 8: 149-163.
40. RADICE G, FERREIRA-CORNWELL MC, ROBINSON SD, RAYBURN H, CHODOSH LA, TAKEICHI M, HYNES RO (1997). Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol 139: 1025-1032.
41. RAYMOND K, CAGNET S, KREFT M, JANSSEN H, SONNENBERG A and GLUKHOVA MA (2011). Control of mammary myoepithelial cell contractile function by alpha3beta1 integrin signalling. EMBO J 30: 1896-1906.
42. RAYMOND K, DEUGNIER MA, FARALDO MM and GLUKHOVA MA (2009). Adhesion within the stem cell niches. Curr Opin Cell Biol 21: 623-629.
43. REVERSI A, CASSONI P and CHINI B (2005). Oxytocin receptor signaling in myoepithelial and cancer cells. J Mammary Gland Biol Neoplasia 10: 221-229.
44. ROSSITER H, BARRESI C, GHANNADAN M, GRUBER F, MILDNER M, FODINGER D and TSCHACHLER E (2007). Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function. FASEB J 21: 3994-4004.
45. RUNSWICK SK, O'HARE MJ, JONES L, STREULI CH and GARROD DR (2001). Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol 3: 823-830.
46. SHACKLETON M, VAILLANT F, SIMPSON KJ, STINGL J, SMYTH GK, ASSELIN-LABAT ML, WU L, LINDEMAN GJ and VISVADER JE (2006). Generation of a functional mammary gland from a single stem cell. Nature 439: 84-88.
47. SLEEMAN KE, KENDRICK H, ROBERTSON D, ISACKE CM, ASHWORTH A and SMALLEY MJ (2007). Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 176: 19-26.
48. SRINIVASAN K, STRICKLAND P, VALDES A, SHIN GC and HINCK L (2003). Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev Cell 4: 371-382.
49. STINGL J, EIREW P, RICKETSON I, SHACKLETON M, VAILLANT F, CHOI D, LI HI and EAVES CJ (2006). Purification and unique properties of mammary epithelial stem cells. Nature 439: 993-997.
50. STRICKLAND P, SHIN GC, PLUMP A, TESSIER-LAVIGNE M and HINCK L (2006). Slit2 and netrin 1 act synergistically as adhesive cues to generate tubular bi-layers during ductal morphogenesis. Development 133: 823-832.
51. TADDEI I, DEUGNIER MA, FARALDO MM, PETIT V, BOUVARD D, MEDINA D, FASSLER R, THIERY JP and GLUKHOVA MA (2008). Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol 10: 716-722.
52. TADDEI I, FARALDO MM, TEULIERE J, DEUGNIER MA, THIERY JP and GLUKHOVA MA (2003). Integrins in mammary gland development and differentiation of mammary epithelium. J Mammary Gland Biol Neoplasia 8: 383-394.
53. WILLIAMS JM and DANIEL CW (1983). Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol 97: 274-290.